ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...
Amylyx Pharmaceuticals (NASDAQ:AMLX) has priced a public offering of ~17.14M shares of its common stock at $3.50 a share. In addition, Amylyx has granted the underwriter a 30-day option to purchase up ...
Starting later this year, Ouro intends to start a phase 1 clinical trial of its own, eyeing the development of the drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback